Joshua Silverman - Apr 5, 2022 Form 4/A - Amendment Insider Report for Synaptogenix, Inc. (SNPX)

Role
Director
Signature
/s/ Robert Weinstein, Attorney-in-fact
Stock symbol
SNPX
Transactions as of
Apr 5, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/23/2022, 06:01 PM
Date Of Original Report
Apr 6, 2022
Previous filing
Feb 3, 2022
Next filing
Apr 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNPX Stock Option (Right to Buy) Other 0 0 Apr 5, 2022 Common Stock, par value $0.0001 per share Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio.